Enalare Therapeutics Receives Additional Funding From BARDA to Further Advance the Development of Agnostic Respiratory Stimulant (ENA-001)
Enalare Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening critical care conditions and community health emergencies, today...
Public Health Vaccines Announces Initiation of First Clinical Trial Evaluating Its Marburg Virus Vaccine
Public Health Vaccines, LLC (PHV), a biotechnology company out of Cambridge, Massachusetts, developing novel products against emerging infectious diseases, has started its Phase 1 clinical...